INS and type 2 diabetes mellitus: RNA-Seq reveals molecular changes at the level of gene regulation in T2DM patients treated with insulin, suggesting that insulin therapy is bidirectional - it can not only reduce the level of inflammation but also cause islet B cell damage and vascular complications.